ArticleThe oncologist2025

Sporadic medullary thyroid carcinoma with a rare RET transmembrane domain mutation (A641R) that responds to selpercatinib.

Naoki Fukuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.